Pharmala Biotech Holdings Inc. (MDXXF)
OTCMKTS
· Delayed Price · Currency is USD
0.1030
0.00 (0.00%)
May 8, 2025, 9:30 AM EDT
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of $9.67 million as of May 9, 2025. Its market cap has decreased by -27.57% in one year.
Market Cap
9.67M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 5.27M to 9.67M, an increase of 83.74%. That is a compound annual growth rate of 20.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 10.51M | -41.47% |
| Dec 31, 2024 | 17.96M | 94.90% |
| Dec 29, 2023 | 9.21M | 500.93% |
| Dec 30, 2022 | 1.53M | -70.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.67B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 761.84M |
| Tian'an Technology Group | 546.22M |
| Glass House Brands | 511.43M |
| CytoDyn | 482.88M |
| Elite Pharmaceuticals | 446.59M |
| Northwest Biotherapeutics | 395.04M |